Dhamija Divyanshu, Bello Adedamola O, Khan Asma A, Gutlapalli Sai Dheeraj, Sohail Mehvish, Patel Priyansh A, Midha Sidharth, Shukla Surmai, Mohammed Lubna
Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Psychiatry, St. Martinus University, Pontiac, USA.
Cureus. 2023 Jun 26;15(6):e40969. doi: 10.7759/cureus.40969. eCollection 2023 Jun.
Cannabis is frequently used by people who self-medicate for the signs of mental health conditions. Attention-deficit/hyperactivity disorder (ADHD), a neurodevelopmental illness, has been linked to increased cannabis use. However, compared to other mental disorders, cannabis use by people with ADHD has received much less research. The main goal of this systematic review was to understand the nature of the relationships between cannabis use and ADHD symptoms. We used Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to conduct the systematic review. We included papers published within the previous ten years from online searches on PubMed, PubMed Central (PMC), Google Scholar, and ScienceDirect until January 1st, 2023. The inclusion-exclusion criteria led to the initial selection of 136 studies. We selected twenty research articles after screening and assessing them using quality assessment techniques. These articles included two non-randomized control trials, one cross-sectional study, one meta-analysis, and sixteen observational cohorts. It can be advantageous for people with ADHD and their medical professionals to understand better how ADHD patients use cannabis and its potential risks and advantages on cannabis use disorder, ADHD symptoms, and executive dysfunction. This article further emphasizes the necessity of thorough research to comprehend cannabis use in ADHD patients.
大麻经常被那些通过自我用药来缓解心理健康状况症状的人使用。注意缺陷多动障碍（ADHD）是一种神经发育疾病，与大麻使用增加有关。然而，与其他精神障碍相比，ADHD患者使用大麻的研究要少得多。本系统评价的主要目的是了解大麻使用与ADHD症状之间关系的本质。我们使用系统评价和Meta分析的首选报告项目（PRISMA）指南进行系统评价。我们纳入了截至2023年1月1日在PubMed、PubMed Central（PMC）、谷歌学术和ScienceDirect上通过在线搜索获得的过去十年内发表的论文。纳入排除标准导致初步筛选出136项研究。我们使用质量评估技术对这些研究进行筛选和评估后，选择了20篇研究文章。这些文章包括两项非随机对照试验、一项横断面研究、一项Meta分析和16项观察性队列研究。对于ADHD患者及其医疗专业人员来说，更好地了解ADHD患者如何使用大麻及其对大麻使用障碍、ADHD症状和执行功能障碍的潜在风险和益处可能是有益的。本文进一步强调了进行深入研究以了解ADHD患者大麻使用情况的必要性。
